Related Experiment Video
Updated: Jul 18, 2026

Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
Published on: September 23, 2022
Vaccination associated thrombocytopenic purpura in children
J Rajantie1, B Zeller, I Treutiger
1Helsinki University Central Hospital, Jorvi Hospital, Finland. jukka.rajantie@hus.fi
Insights
Vaccinations, including the MMR vaccine, rarely cause acute immune thrombocytopenia (ITP) in children. Most cases resolve quickly with minimal bleeding, indicating a favorable outcome.
Area of Science:
- Pediatric Hematology
- Vaccine Safety
- Immunology
Background:
- Immune thrombocytopenia (ITP) is an autoimmune disorder characterized by low platelet counts.
- Vaccination is a potential trigger for ITP in susceptible individuals.
- Understanding the incidence and outcomes of vaccine-associated ITP is crucial for public health.
Purpose of the Study:
- To determine the risk of developing ITP following vaccination in pediatric patients.
- To characterize the clinical presentation and outcomes of vaccine-associated ITP.
- To compare the incidence of ITP after vaccination versus natural infections.
Main Methods:
- Retrospective analysis of a population-based cohort of 506 pediatric patients with newly diagnosed ITP.
- Identification of patients who developed purpura and thrombocytopenia (<30x10(9)/l) within one month post-vaccination.
- Detailed review of clinical symptoms, vaccination history, and follow-up data.
Main Results:
- Twenty-four out of 35 patients with post-vaccination ITP received the MMR vaccine, estimating an ITP risk of approximately 1 in 30,000 MMR inoculations.
- Symptoms were typically acute, with 74% of patients recovering within one month.
- Fewer than 10% experienced prolonged thrombocytopenia (>6 months), and bleeding episodes were infrequent.
Conclusions:
- The incidence of symptomatic thrombocytopenia following vaccination is significantly lower than after natural infections.
- Pediatric ITP following vaccination generally presents acutely and has an excellent prognosis.
- Vaccine-associated ITP risk is low, and outcomes are favorable, supporting continued vaccination programs.
Abstract:
Patients who presented with purpura and blood platelets <30x10(9)/l within 1 month after vaccination were collected from a population based material of 506 consecutive pediatric patients with newly diagnosed ITP. Of the 35 such patients, 24 had thrombocytopenia after MMR vaccination giving an estimated ITP risk of approximately 1 in 30,000 MMR inoculations. Symptoms of the 35 patients were nearly always acute. Thrombocytopenia disappeared within a month in 74% of the study patients and lasted longer than 6 months in only 10%. Bleeding episodes were uncommon during the follow-up period. We conclude that the incidence of symptomatic thrombocytopenia after vaccinations is much lower than that after respective natural infections and that the outcome in most cases is excellent.
Related Concept Videos
Poliomyelitis
Vaccinations
Chickenpox
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Respiratory Syncytial Virus Disease
